Article

The effectiveness of EEG-feedback on attention, impulsivity and EEG: a sham feedback controlled study.

Department of Experimental Psychology, Utrecht University, Utrecht, The Netherlands.
Neuroscience Letters (Impact Factor: 2.06). 07/2010; 479(1):49-53. DOI: 10.1016/j.neulet.2010.05.026
Source: PubMed

ABSTRACT EEG-feedback, also called neurofeedback, is a training procedure aimed at altering brain activity, and is used as a treatment for disorders like Attention Deficit/Hyperactivity Disorder (ADHD). Studies have reported positive effects of neurofeedback on attention and other dependent variables. However, double-blind studies including a sham neurofeedback control group are lacking. The inclusion of such group is crucial to control for unspecific effects. The current work presents a sham-controlled, double-blind evaluation. The hypothesis was that neurofeedback enhances attention and decreases impulsive behavior. Participants (n=27) were students selected on relatively high scores on impulsivity/inattention questionnaires (Barrat Impulsivity Scale and Broadbent CFQ). They were assigned to a neurofeedback treatment or a sham group. (sham)Neurofeedback training was planned for 15 weeks consisting of a total of 30 sessions, each lasting 22 min. Before and after 16 sessions (i.e., interim analyses), qEEG was recorded and impulsivity and inattention was assessed using a stop signal task and reversed continuous performance task and two questionnaires. Results of the interim analyses showed that participants were blind with respect to group inclusion, but no trend towards an effect of neurofeedback on behavioral measures was observed. Therefore in line with ethical guidelines the experiment was ceased. These results implicate a possible lack of effect of neurofeedback when one accounts for non-specific effects. However, the specific form of feedback and application of the sham-controlled double-blind design may have diminished the effect of neurofeedback.

2 Followers
 · 
166 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this pilot study the effect of attention (covert and overt) on the signal detection and classification of steady-state visual-evoked potential (SSVEP) were investigated. Using the SSVEP-based paradigm, data were acquired from 4 subjects using 3 scalp electroencephalography (EEG) electrodes located on the visual area. Subjects were instructed to perform the attention task in which they attended covertly or overtly to either of the stimuli flickering with different frequencies (6, 7, 8 and 9Hz). We observed a decrease in signal power in covert compared to the overt attention. However, there was a consistent pattern in covert attention causing an increase in the power of the 2(nd) harmonic of the attended frequency. Encouraging results of this preliminary study indicates that it can be adapted and implemented in the brain-computer interface (BCI) system which could potentially be used as a neuro-rehabilitation tool for individuals with attention deficit.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article presents an ethnographical and historical analysis of the mode of being that is constituted when people use neurofeedback (brainwave training) for self-improvement. I analyse how human brainwaves have been associated with the psyche since their first demonstration by the psychiatrist Hans Berger, how they were connected to personality types by the cyberneticist Grey Walter, and made trainable by the psychologists Joe Kamiya and Barry Sterman. I compare these cases with the reports of contemporary neurofeedback practitioners and users, and demonstrate that working on the self by working on the brain constitutes a complicated relationship between the brain and the self. Moreover, I demonstrate that combinations of brains and selves, material and spiritual ideas, and biological and social explanations are not confusions due to the ignorance of neurofeedback users, but amalgamations that emerged in the work and ideas of early scientists.
    History of the Human Sciences 01/2015; DOI:10.1177/0952695114566644 · 0.28 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Treatment for children with attention deficit/hyperactivity disorder (ADHD) today is predominantly pharmacological. While it is the most common treatment, it might not always be the most appropriate one. Moreover, long term effects remain unclear. Behavior therapy (BT) and non-pharmacological treatments such as neurofeedback (NF) are promising alternatives, though there are no routine outpatient care/effectiveness studies yet that have included children with medication or changes in medication. This paper presents the protocol of a randomized controlled trial to compare the effectiveness of a Slow Cortical Potential (SCP) NF protocol with self-management (SM) in a high frequent outpatient care setting. Both groups (NF/SM) receive a total of 30 high frequent therapy sessions. Additionally, 6 sessions are reserved for comorbid problems. The primary outcome measure is the reduction of ADHD core symptoms according to parent and teacher ratings. Untill now 58 children were included in the study (48 males), with a mean age of 8.42 (1.34) years, and a mean IQ of 110 (13.37). Conners-3 parent and teacher ratings were used to estimate core symptom change. Since the study is still ongoing, and children are in different study stages, pre-post and follow-up results are not yet available for all children included. Preliminary results suggest overall good pre-post effects, though. For parent and teacher ratings an ANOVA with repeated measures yielded overall satisfying pre-post effects (η (2) 0.175-0.513). Differences between groups (NF vs. SM) could not yet be established (p = 0.81). This is the first randomized controlled trial to test the effectiveness of a NF protocol in a high frequent outpatient care setting that does not exclude children on or with changes in medication. First preliminary results show positive effects. The rationale for the trial, the design, and the strengths and limitations of the study are discussed. This trial is registered in www.clinicaltrials.gov as NCT01879644.
    Frontiers in Human Neuroscience 01/2014; 8:943. DOI:10.3389/fnhum.2014.00943 · 2.90 Impact Factor